Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction

Atherosclerotic Plaque Fissuration and Clinical Outcomes in Pre-Diabetics vs. Normoglycemics Patients Affected by Asymptomatic Significant Carotid Artery Stenosis at 2 Years of Follow-Up: Role of microRNAs Modulation: The ATIMIR Study

(2021) Celestino Sardu et al.   Biomedicines

2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up

(2020) Celestino Sardu et al.   JACC-Cardiovascular Imaging

Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients

(2019) Nunzia D’Onofrio et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Effects of metformin therapy on COronary endothelial DYsfunction in prediabetic patients With stable angina and Non Obstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study

(2019) Celestino Sardu et al.   DIABETES CARE

Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study

(2019) Ferdinando Carlo Sasso et al.   Cardiovascular Diabetology

MicroRNA‐33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients

(2019) Nunzia D'Onofrio et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin

(2019) Celestino Sardu et al.   Cardiovascular Diabetology

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management

(2018) Michaël J.B. van Baar et al.   DIABETES CARE

Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes

(2018) W. Timothy Garvey et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients

(2018) Celestino Sardu et al.   Frontiers in Physiology

Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.

(2018) Hiroto Oshima et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Pericoronary Adipose Tissue: A Novel Therapeutic Target in Obesity-Related Coronary Atherosclerosis

(2015) Tomasz Mazurek et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION